Products for Research Use Only
RegisterLogin

Inotuzumab

CAT: 0804-HY-P99264-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99264-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent Ozogamicin as an antibody-drug conjugate (ADC), Inotuzumab ozogamicin. Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma[1][2][3][4].
CAS Number
1660159-36-3
Product Name Alternative
Humanized Anti-CD22 Recombinant Antibody
UNSPSC
12352203
Target
ADC Antibody; Apoptosis; CD22
Type
Inhibitory Antibodies
Related Pathways
Antibody-drug Conjugate/ADC Related; Apoptosis; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/inotuzumab.html
Purity
96.81
Solubility
10 mM in DMSO
Smiles
[Inotuzumab]
Molecular Weight
(146.48 kDa)
References & Citations
[4]Betts AM, et al. Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin. AAPS J. 2016 Sep;18 (5) :1101-1116.|[1]Aujla A, et al. Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Biomark Res. 2019 Apr 11;7:9.|[2]Wynne J, et al. Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia. Blood Adv. 2019 Jan 8;3 (1) :96-104.|[3]Kirchhoff H, et al. Venetoclax and dexamethasone synergize with inotuzumab ozogamicin-induced DNA damage signaling in B-lineage ALL. Blood. 2021 May 13;137 (19) :2657-2661.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 4

Alternative Products

CatalogName
BA2316-1Inotuzumab
T9901A-220-01Inotuzumab MMAE
GTR18337995-01Inotuzumab Antibody
HB011026-01Research Grade Inotuzumab
E55B0728Inotuzumab (Reference antibody)
591929Inotuzumab Ozogamicin (CD22)
GTR18578296-01Inotuzumab MMAE Antibody
ICH5247-5mgInotuzumab Biosimilar - Research Grade
GTR18780601-01(Inotuzumab) Biosimilar Reference Antibody
GTR18697460-01Inotuzumab Human Monoclonal Antibody

Popular Products